Issue 1/2002
Content (13 Articles)
Suicide gene therapy using E. coli β-galactosidase
David Farquhar, Bih Pan, Mamoru Sakurai, Ajit Ghosh, Craig A. Mullen, Arly J. Nelson
Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro
Verena Jendrossek, Kerstin Hammersen, Bernhard Erdlenbruch, Wilfried Kugler, Regina Krügener, Hansjörg Eibl, Max Lakomek
Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia
D. Lancaster, N. Patel, L. Lennard, J. Lilleyman
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study
Robert E. Martell, Bercedis L. Peterson, Harvey Cohen, William P. Petros, Kanti R. Rai, Vicki A. Morrison, Laurence Elias, Lois Shepherd, John Hines, Richard A. Larson, Charles A. Schiffer, Herbert I. Hurwitz
Urinary and fecal excretion of topotecan in patients with malignant solid tumours
Virginie M. Herben, Nadja Schoemaker, Hilde Rosing, Desiree M. van Zomeren, Wim W. ten Bokkel Huinink, Ria Dubbelman, Solange Hearn, Jan H. Schellens, Jos H. Beijnen
Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function
Masataka Ikeda, Hiroshi Furukawa, Hiroshi Imamura, Jyunzo Shimizu, Hideyuki Ishida, Seizo Masutani, Masayuki Tatsuta, Takatoshi Kawasaki, Takashi Satomi
A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling
H. van den Bongard, R. Mathôt, O. van Tellingen, J. Schellens, J. Beijnen
A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer
Christopher W. Ryan, Everett E. Vokes, Nicholas J. Vogelzang, Linda Janisch, Ken Kobayashi, Mark J. Ratain
The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer
Rachel J. Gibson, Dorothy M. Keefe, Julie M. Clarke, Geoff O. Regester, Fiona M. Thompson, Gary J. Goland, Ben G. Edwards, Adrian G. Cummins
Rapid biotransformation of satraplatin by human red blood cells in vitro
Jocelyn L. Carr, Malcolm D. Tingle, Mark J. McKeage
Pilot study of gemcitabine (10 mg/m2 per min) and cisplatin
Elizabeth Poplin, Al Benson, Rita Musanti, Eric Rubin, Mary Mulcahy
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer
Daniel J. Booser, Francisco J. Esteva, Edgardo Rivera, Vicente Valero, Laura Esparza-Guerra, Waldemar Priebe, Gabriel N. Hortobagyi
Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells
A. Munshi, T. McDonnell, R. Meyn